PT - JOURNAL ARTICLE AU - Barbara Leticia da Silva Guedes de Moura AU - Anderson Gusthavo dos Santos Mucenieks AU - Enrico Prajiante Bertolino AU - Giordanna Chiqueto Duarte AU - João Vitor Dudek AU - Mariana Amâncio Daniel da Silva AU - Izabel Galhardo Demarchi AU - Sergio Seiji Yamada AU - Rogerio Toshiro Passos Okawa AU - Jorge Juarez Vieira Teixeira TI - Prognostic implications of Global Longitudinal Strain versus Ejection Fraction in End-stage Renal Disease: a systematic review protocol AID - 10.1101/2022.07.29.22278210 DP - 2022 Jan 01 TA - medRxiv PG - 2022.07.29.22278210 4099 - http://medrxiv.org/content/early/2022/07/30/2022.07.29.22278210.short 4100 - http://medrxiv.org/content/early/2022/07/30/2022.07.29.22278210.full AB - Background In hemodialysis (HD) patients, the presence of Heart failure (HF) at the start of dialysis is a strong and independent predictor of short and long-term mortality, and its prevalence increases with declining kidney function and HD time. Left ventricular (LV) ejection fraction (EF) is widely used as a measure of systolic function. Reduced EF (<50%) is an important prognostic marker, however, less than 15% of End-stage Renal Disease (ESRD) patients have detectable systolic dysfunction and the EF is susceptible to loading conditions, which change dramatically during interdialytic intervals. Global Longitudinal Strain (GLS) derived by 2D Speckle-Tracking Echocardiography (STE) is an emerging technique for measuring more subtle disturbances in LV systolic function. Although ESRD patients have subclinical evidence of impaired strain but preserved EF, there is evidence that GLS is better in ESRD group receiving maintenance HD compared with moderate-advanced CKD patients. This systematic review will evaluate the evidence related to the incremental prognostic value of LV GLS by 2D-STE concerning mortality and cardiovascular (CV) events in ESRD patients.Methods This protocol is reported according to the PRISMA-P guideline. The databases PubMed, EMBASE, LILACS, Web of Science, and Google Scholar system will be searched and double screening for longitudinal studies that assessed the prospective association of STE-derived parameters with at least one of the pre-specified outcomes in ESRD patients. Discrepancies will be resolved through consensus. A modified version of the Newcastle-Ottawa Quality Assessment Scale of cohort studies will be used. We intend to use the random-effects model, considering at least moderate heterogeneity between studies. If data allow, we will perform meta-regression to explore potential sources of between-study heterogeneity. An adaptation of the GRADE framework for prognostic studies will be employed to judge the quality of evidence for each outcome reported in this systematic review.Discussion This systematic review will summarize current evidence about STE-derived measures in the ESRD patients and clarify the incremental prognostic value of this diagnostic tool versus LVEF in these patients. Evidence about other measures (circumferential and radial strain) or 3D STE-derived indices will also be investigated.Systematic review registration This systematic review protocol was submitted to the PROSPERO international registry of systematic reviews (Registration number: CRD42020222505).Strengths and limitations of this study→ The PROSPERO registry helps to promote and maintain transparency in the process and to assist in minimizing the risk of bias. Four databases and one additional grey literature source helps ensure more complete coverage of the topic. A modified version of the Newcastle-Ottawa Quality Assessment Scale of cohort studies will be used and an adaptation of the GRADE framework for prognostic studies to assess the quality of evidence for each outcome reported will be applied. All the review phases will be peer-reviewed and will be validated by methodological and clinical experts.→ Left ventricular (LV) ejection fraction (EF) is widely used as a measure of systolic function. Reduced EF (50%) is an important prognostic marker, however, less than 15% of End-Stage Renal Disease (ESRD) patients have detectable systolic dysfunction. Global Longitudinal Strain (GLS) derived by 2D Speckle-Tracking Echocardiography (STE) is an emerging technique for measuring more subtle disturbances in LV systolic function, however, its incremental prognostic value to ESRD is controversial.→ This study has limitations. Because heterogeneity is quite common in these systematic reviews, there may be limited scope for meta-analysis. Possibly, the spectrum of patients in different research sites is the main factor, in most cases, but heterogeneity in associations between studies may be difficult to explain.→ This systematic review will evaluate the evidence related to the GLS incremental prognostic value in End-Stage Renal Disease patients, which may lower morbidity and mortality and influence its use as a prognostic marker for ESRD patients.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020222505 Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data generated or analyzed during this study are included in this published article [and its supplementary information files].AFAtrial fibrillationAICDAutomatic implantable cardioverter defibrillatorCHDCoronary heart diseaseCMRCardiovascular magnetic resonance imagingCRSCardiorenal syndromeCVDCardiovascular diseaseDMDiabetes mellitusEFEjection fractionESRDEnd-Stage Renal DiseaseGLSGlobal Longitudinal StrainHDHemodialysisHFHeart failureLILACSLatin American and Caribbean Literature in Health SciencesLVLeft ventricularMIMyocardial infarctionNOSNewcastle-Ottawa Quality Assessment Scale of cohort studiesPRISMA-PPreferred Reporting Items for Systematic Reviews and Meta-Analyses ProtocolsPROSPEROInternational registry of systematic reviewsRRTRenal replacement therapySTESpeckle-tracking echocardiographyUCUremic cardiomyopathy